The core activity of INTLAB AG is the development and application of pharmacogenetics, particularly in the field of personalized medicine. The company offers solutions for optimizing drug treatments in various specialties such as oncology, psychiatry, cardiology and pain management. The specific medications that INTLAB works with include 5-FU/Capecitabine, Clopidogrel and Tamoxifen.
AI-generated
Offering
Products & services
Industry:Research & Development
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Pharmacogenetic tests to analyze genetic variants that influence the efficacy and tolerability of medications; the basis for personalized dosing and active ingredient selection.
SONOGEN
SONOGEN expert system for pharmacogenetics with one-stop services, interpretation of test results and tailoring to specialist areas such as oncology, psychiatry, cardiology and pain medicine.